New Directions in Immuno-oncology: Response and Resistance

​Description:

Immuno-oncology, the approach of harnessing the immune system to help fight cancer, has emerged in the last decade as one of the fastest-growing areas in cancer research with hundreds of potential treatments under investigation. As the field has accelerated, the issue of immuno-oncology resistance has arisen and is now a key area of high unmet medical need for cancer researchers to understand and address. 

Join us in February for a series of interactive digital sessions dedicated to the latest breakthroughs in cell therapies, resistance to immunotherapies (tumor microenvironment and overcoming acquired resistance), and multiplex technologies. Gain insights into approaches impacting the field with talks from thought leaders across industry and academia, and opportunities to discuss key topics in live Q&A sessions.

Live sessions:​

• Cell therapies: Super charging the immune system
• Resistance to immunotherapies: Turning cold into hot - firing up the TME
• Resistance to immunotherapies: Mechanisms to overcome acquired resistance
• Multiplex technologies to advance immuno-oncology and oncology discoveries
  
  

Save my place
​​

P.A.C.E credits:

Abcam is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. P.A.C.E credits are available for the live sessions and can be requested after each session. 

​​Cell therapies: Super charging the immune system

February 3, 2021
​4pm-6pm CET | 3pm-5pm GMT | 10am-12pm EST | 7am-9am PST

Speakers:

• Maike de la Roche, University of Cambridge, UK
• Amir Horowitz, Icahn School of Medicine at Mount Sinai, USA
• Uriel Moreno, Johnson & Johnson, USA
• Shimobi Onuoha, Autolus, UK
  
  

​Resistance to immunotherapies: Turning cold into hot - firing up the TME

February 10, 2021
4pm-6pm CET | 3pm-5pm GMT | 10am-12pm EST | 7am-9am PST

Speakers:

• Michael Curran, MD Anderson Cancer Center, USA
• Andrew Mellor, Newcastle University, UK
• Luigi Ombrato, Barts Cancer Institute - Queen Mary University of London, UK
  
  

​​Resistance to immunotherapies: Mechanisms to overcome acquired resistance

February 18, 2021
4pm-6pm CET | 3pm-5pm GMT | 10am-12pm EST | 7am-9am PST

Speakers:

• Rüdiger Greinert, Elbekliniken Stade/Buxtehude, Germany
• Benjamin Izar, Columbia University, USA
• Mari Mino-Kenudson, Massachusetts General Hospital, USA
• George Prendergast, The Lankenau Institute for Medical Research, USA
  
  

​Multiplex technologies to advance immuno-oncology and oncology discoveries​

​February 23, 2021
4pm-6pm CET | 3pm-5pm GMT | 10am-12pm EST | 7am-9am PST

Speakers:

• Adrien Guillot, Charité - Universitätsmedizin Berlin, Germany
• Leeat Keren, Weizmann Institute of Science, Israel
• Joe Yeong, A*STAR, Singapore

​Registration:

• Register once to attend all four sessions
• All registered attendees will receive an email confirmation from no-reply@zoom.us with your unique URL to join the webinar. Please contact the Abcam Events Team if you have any questions. 

​
​Share with a friend:

Don't forget to share this event with your friends and colleagues! Attend the sessions and have a discussion on what you've all discovered! You can share by email or using the social media buttons at the top of the page.
​

Contact:

Have a question? Please contact the Abcam Events Team.